1.- Cancer - depression and psychosocial distress: percentage of patients diagnosed with depression for whom a treatment plan for depression was documented.
full-text:
National Quality Measures Clearinghouse | Cancer - depression and psychosocial distress: percentage of patients diagnosed with depression for whom a treatment plan for depression was documented.
2.- Cancer - depression and psychosocial distress: percentage of patients treated for depression for whom a response to therapy was documented within 6 weeks.
full-text:
National Quality Measures Clearinghouse | Cancer - depression and psychosocial distress: percentage of patients treated for depression for whom a response to therapy was documented within 6 weeks.
3.- Cancer - nausea and vomiting: percentage of inpatients with nausea or vomiting who were offered a change in therapy within 24 hours of the initial report of nausea or vomiting.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of inpatients with nausea or vomiting who were offered a change in therapy within 24 hours of the initial report of nausea or vomiting.
4.- Cancer - nausea and vomiting: percentage of outpatients not receiving chemotherapy or radiation who were treated for nausea or vomiting with an antiemetic medication for whom the effectiveness of treatment was evaluated before or on the next visit to the same outpatient site.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of outpatients not receiving chemotherapy or radiation who were treated for nausea or vomiting with an antiemetic medication for whom the effectiveness of treatment was evaluated before or on the next visit to the same outpatient site.
5.- Cancer - nausea and vomiting: percentage of patients undergoing chemotherapy treatment with a high acute emetic risk for whom a 3-drug regimen including single doses of a 5-HT3 receptor antagonist, dexamethasone, and selective neurokinin-1 receptor blocker was given immediately prior to chemotherapy.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of patients undergoing chemotherapy treatment with a high acute emetic risk for whom a 3-drug regimen including single doses of a 5-HT3 receptor antagonist, dexamethasone, and selective neurokinin-1 receptor blocker was given immediately prior to chemotherapy.
6.- Cancer - nausea and vomiting: percentage of patients undergoing chemotherapy treatment with a moderate acute emetic risk for whom a 2-drug regimen including a 5-HT3 receptor antagonist and dexamethasone were given immediately prior to chemotherapy.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of patients undergoing chemotherapy treatment with a moderate acute emetic risk for whom a 2-drug regimen including a 5-HT3 receptor antagonist and dexamethasone were given immediately prior to chemotherapy.
7.- Cancer - nausea and vomiting: percentage of patients undergoing moderately or highly emetic chemotherapy or with cancer affecting the gastrointestinal tract or abdomen seen for a visit in a cancer-related outpatient setting for whom the presence or absence of nausea or vomiting was assessed at every visit.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of patients undergoing moderately or highly emetic chemotherapy or with cancer affecting the gastrointestinal tract or abdomen seen for a visit in a cancer-related outpatient setting for whom the presence or absence of nausea or vomiting was assessed at every visit.
8.- Cancer - nausea and vomiting: percentage of patients who report nausea or vomiting on admission to the hospital for whom potential underlying causes were assessed within 24 hours.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of patients who report nausea or vomiting on admission to the hospital for whom potential underlying causes were assessed within 24 hours.
9.- Cancer - nausea and vomiting: percentage of patients with advanced cancer affecting the gastrointestinal tract or abdomen admitted to a hospital for whom the presence or absence of nausea or vomiting was assessed within 24 hours.
full-text:
National Quality Measures Clearinghouse | Cancer - nausea and vomiting: percentage of patients with advanced cancer affecting the gastrointestinal tract or abdomen admitted to a hospital for whom the presence or absence of nausea or vomiting was assessed within 24 hours.
No hay comentarios:
Publicar un comentario